- Supported exchanges /
- KLSE /
- 7148.KLSE
Duopharma Biotech Bhd (7148 KLSE) stock market data APIs
Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products comprising vitamins and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides specialty pharmaceutical drugs for targeted conditions, biosimilar products, and medical devices and consumables to patients with conditions, such as diabetes, cancer, cardiovascular diseases, renal diseases, and others. The company's product portfolio comprises vascor, acetan, covasc, crystorvas, bezartan, vytan, and vytocor; insugen and basalog one; kytron, zuhera, lebreta, trevive, and krabeva; and unihepa, ranofer, erysaa, bi-haemosol, and haemosol. The company offers its products under the Champs, Flavettes, Eye Glo, Proviton, Naturalle, and Uphamol brands. In addition, it offers property management and services; and distributes, imports, and exports chemical products. The company was formerly known as CCM Duopharma Biotech Berhad and changed its name to Duopharma Biotech Berhad in February 2019. Duopharma Biotech Berhad was founded in 1978 and is headquartered in Kuala Lumpur, Malaysia.
Duopharma Biotech Bhd Financial Data Overview
1.24 | |
1.24 | |
- | |
1.25 | |
1.24 | |
1.091-1.45 | |
1 183 M | |
24.4 | |
962 M | |
788 M | |
0.0162 | |
0.0228 | |
0.684 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Duopharma Biotech Bhd Fundamental Data is available in our Financial Data APIs
- Net Revenue 788 M
- EBITDA 130 M
- Earnings Per Share 0.05
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Duopharma Biotech Bhd Earnings via APIs
- Latest Release 2024-11-14
- EPS/Forecast NaN
Get Duopharma Biotech Bhd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: